Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Agra Ventures Ltd C.AGRA

Agra Ventures Ltd. is a Canada-based diversified company focused on the international cannabis industry. The Company is engaged in the cultivation, distribution and marketing of cannabis and cannabis-infused products around the world. It has a portfolio of licensed upstream, downstream, and product formulation assets. Its primary asset in Canada is Boundary Bay Cannabis, a cannabis greenhouse facility focused on the cultivation of high-potency cannabis. The Company's wholly owned subsidiary, Farmako GmbH (Farmako), is a distributor of medical cannabis. Farmako distributes the products in its network of German pharmacies. Its products have Farmako's branding. The products initially include high potency tetrahydrocannabinol (THC) flower and balanced THC and cannabidiol (CBD) flower. Farmako has product distribution operations in Germany and in the United Kingdom.


CSE:AGRA - Post by User

Comment by Toweringmarson Jan 17, 2020 10:56am
234 Views
Post# 30565019

RE:PS I rarely share data from my modeling workups.

RE:PS I rarely share data from my modeling workups. What sort of EPS do you think Agra can reasonably pull off? What kind of EPS is needed to shift the needle at all here? Do you think they can ever encroach on a positive EBITDA in the next two years? Seems to me they keep buying assets that arent generating profits, and cant seem to turn them into any sort of profitable entity. I see many other companies starting to get things right on a smaller scale, yet we cant seem to even get something going. A pile of strains (when most companies are growing 3 - 5 at most). A pile of brands, yet none are in production yet and there are really no barriers to entry while we're late to the game. Sure hope they can pull a rabbit out of a hat here, but theres a reason why we're priced the way we are and have been diluted to death. Would be interested to hear your take Tex.
<< Previous
Bullboard Posts
Next >>